Search results for "RED"

showing 10 items of 23890 documents

Enzymatic Determination in Serum of Lathyritic and Prednisone-treated Lathyritic Rats

1966

WHILE a remarkably raised serum-level of transaminases and aldolase is found in dermatomyositis, such augmentation, as a rule, is not found in cases of severe muscular involvement of scleroderma and disseminated lupus erythematosus (acutus)1–3.

medicine.medical_specialtyeducationLathyrismFructose-bisphosphate aldolaseSclerodermachemistry.chemical_compoundimmune system diseasesPrednisoneFructose-Bisphosphate AldolaseInternal medicinemedicineAnimalsAspartate Aminotransferasesskin and connective tissue diseasesCyanidesMultidisciplinaryL-Lactate DehydrogenasebiologyLathyrismbusiness.industryAldolase AAlanine TransaminaseAminopropionitrileDermatomyositismedicine.diseasehumanitiesRatsEndocrinologyAlanine transaminasechemistryAminopropionitrilebiology.proteinPrednisonebusinessmedicine.drugNature
researchProduct

Pasteurized C1 inhibitor concentrate in hereditary angioedema: pharmacology, safety, efficacy and future directions

2010

Hereditary angioedema (HAE) is a relatively rare genetic disorder that is most commonly caused by a deficiency of C1 inhibitor. It is estimated that HAE affects at least one in 10,000 to one in 50,000 of the worldwide population, with relapsing swelling of the skin and abdominal pain attacks being the most common clinical symptoms. Most seriously, laryngeal edema associated with HAE may lead to death. Replacement therapy with intravenous pasteurized C1 inhibitor concentrate is the recommended treatment for acute attacks of HAE, resulting in a rapid resolution of symptoms. Pasteurized C1 inhibitor concentrates can also be used for prophylaxis of HAE, and are currently also being assessed for…

medicine.medical_specialtyeducation.field_of_studyAbdominal painAngioedemabiologybusiness.industryImmunologyPopulationGenetic disorderLaryngeal Edemamedicine.diseaseDermatologySurgeryC1-inhibitorHereditary angioedemamedicinebiology.proteinImmunology and Allergymedicine.symptomeducationbusinessDisease burdenExpert Review of Clinical Immunology
researchProduct

Preliminary prediction model for identifying patients with the possibility of pharmacotherapy improvement

2010

Abstract Objective To develop a prediction model for identifying patients with the possibility of improving pharmacotherapy during the process of pharmaceutical validation of the prescription. Method Cross-sectional study over two months, performed in the Internal Medicine and Infectious Disease divisions. Detecting opportunities for improving quality of pharmacotherapy is done by means of a pharmacist's validation of the prescription. Based on the information we obtained through this process, we performed a multivariate logistic regression analysis using as prognostic factors the demographic, pharmacotherapy and clinical variables related to identifying any drug-related problems (DRPs) in …

medicine.medical_specialtyeducation.field_of_studyCross-sectional studybusiness.industryPopulationPharmacistArea under the curveLogistic regressionSurgeryPharmacotherapyEmergency medicineMedicinePredictive variablesMedical prescriptionbusinesseducationFarmacia Hospitalaria (English Edition)
researchProduct

The Association Between Smoking Status and Depression in the General Population of Latvia

2015

Introduction Tobacco dependence is the most common substance use disorder in people with mental illness. Smoking and depression are firmly associated and both represent major health problems. Aim The aim of the study was to assess association between smoking status and 12-months depression in representative sample of the general Latvian population. Methods The study was a part of health monitoring survey, a collaborative project between Baltic States and Finland, which monitors health related behaviours; the questionnaire included structured interview and depressive module of the Mini International Neuropsychiatric Interview. Descriptive statistics and binary regression model were applied. …

medicine.medical_specialtyeducation.field_of_studyDescriptive statisticsbusiness.industryPopulationmedicine.diseaseMental illnessSubstance abusePsychiatry and Mental healthStructured interviewmedicineAssociation (psychology)PsychiatryeducationbusinessDepression (differential diagnoses)DemographyMini-international neuropsychiatric interviewEuropean Psychiatry
researchProduct

Sleep disordered breathing in patients with cardiovascular comorbidities hospitalized for pulmonary disease

2015

Sleep disordered breathing (SDB) is often overlooked in hospitalized patients. We screened consecutive patients with cardiovascular (CV) comorbidities hospitalized for respiratory problems to study SDB prevalence and type. Patients did not refer typical clinical signs of SDB. Patients (n=34, 21 M, mean age±SD 71±12 yr, BMI: 31.9±5.8 kg/m2) were studied by polygraphy (SomnoLab, Weinmann, Germany) 4.5±3.2 days after admission for COPD exacerbation (COPD-E, n=20), pleural effusion (n=2), asthma exacerbation (n=2) or other causes (n=10). On admission, 18 patients showed respiratory failure (RF, hypoxemic: n=9, hypercapnic: n=9). CV comorbidities (1.7±0.8/patient) were: hypertension (n= 27), hea…

medicine.medical_specialtyeducation.field_of_studyPediatricsbusiness.industryPleural effusionPopulationmedicine.diseasenervous system diseasesrespiratory tract diseasesHypoxemiamedicine.anatomical_structureRespiratory failureInternal medicineHeart failuremental disordersSleep disordered breathingmedicineCardiologycardiovascular diseasesRespiratory systemmedicine.symptomeducationbusinessArtery4.2 Sleep and Control of Breathing
researchProduct

Cost-effectiveness analysis of statins in primary care: results from the Arteris cohort study.

2021

BACKGROUND The Swiss Federal Office of Public Health performed a health technology assessment regarding statins in primary care. The chosen models may lead to a situation where a clinically indicated statin therapy is estimated not to be cost effective. METHODS We performed a cohort study regarding cardiovascular events, comparing SCORE and AGLA risk categories with tertiles of carotid plaque burden and used two models for cost-effectiveness analysis of high-potency statins. RESULTS Subjects (n = 2842) were followed up for 5.9 ± 2.9 years with the occurrence of 154 cardiovascular events (extrapolated 10-year risk was 9.2%). Carotid plaque imaging (total plaque area, TPA) significantly impro…

medicine.medical_specialtyeducation.field_of_studyPrimary Health Carebusiness.industryPublic healthCost-Benefit AnalysisPopulationMEDLINEGeneral MedicineCost-effectiveness analysisPrimary careCohort StudiesIndirect costsEmergency medicineMedicineHumansCarotid imagingQuality-Adjusted Life YearsHydroxymethylglutaryl-CoA Reductase InhibitorsbusinesseducationCohort studySwiss medical weekly
researchProduct

Long-Term Efficacy of Radiofrequency Treatment of Turbinate Hypertrophy: A Patient Based Point of View

2010

Nasal turbinate hypertrophy is a major cause of nasal airway obstruction that affects up to 20% of the European general population. This study aims to determine the efficacy of radiofrequency treatment as perceived by patients during a 2-years period. From 2007 to 2009, an observational study was conducted on 36 patients who consecutively underwent temperature-controlled radiofrequency tissue volume reduction. A questionnaire was administered to each patient in order to collect demographic data, lifestyle habits, health status and visual analogue scale (VAS) score of perceived symptoms. Mean VAS scores of nasal obstruction, headache, rhinorrhoea and anosmia after treatment were significantl…

medicine.medical_specialtyeducation.field_of_studybusiness.industryVisual analogue scaleTURBINATE RADIOFREQUENCY NASAL OBSTRUCTION TISSUE REDUCTIONPopulationAnosmiaSettore MED/42 - Igiene Generale E ApplicataMuscle hypertrophySurgerySettore MED/31 - OtorinolaringoiatriaOtorhinolaryngologyOtorhinolaryngologyInternal medicineMedicineOriginal ArticleSurgeryObservational studymedicine.symptombusinesseducationAfter treatmentTissue volumeIndian Journal of Otolaryngology and Head & Neck Surgery
researchProduct

Primary Persistent Atrial Fibrillation: A Distinct Arrhythmia Subentity of an Ablation Population

2015

INTRODUCTION Persistent atrial fibrillation (persAF) can occur either as a sustained arrhythmia that has progressed from initially paroxysmal AF or as primary persAF without a history of any spontaneously terminated episode. There is a paucity of data differentiating between the 2 different persAF entities. Thus, we prospectively evaluated baseline characteristics, electrophysiological features, and ablation outcome in these 2 patient cohorts. METHODS AND RESULTS A total number of 154 consecutive persAF patients (63 ± 10 years, f = 42, longstanding persAF = 60) were characterized in terms of having primary persAF (P-persAF group) or persAF that secondarily progressed from paroxysmal AF (S-p…

medicine.medical_specialtyeducation.field_of_studybusiness.industrymedicine.medical_treatmentPopulationCatheter ablationAtrial fibrillationAblationmedicine.diseasePhysiology (medical)Heart failurePredictive value of testsInternal medicineCardiologyMedicineMedical historyCardiology and Cardiovascular MedicinebusinessProspective cohort studyeducationJournal of Cardiovascular Electrophysiology
researchProduct

Statins stimulate the production of a soluble form of the receptor for advanced glycation end products

2013

The beneficial effects of statin therapy in the reduction of cardiovascular pathogenesis, atherosclerosis, and diabetic complications are well known. The receptor for advanced glycation end products (RAGE) plays an important role in the progression of these diseases. In contrast, soluble forms of RAGE act as decoys for RAGE ligands and may prevent the development of RAGE-mediated disorders. Soluble forms of RAGE are either produced by alternative splicing [endogenous secretory RAGE (esRAGE)] or by proteolytic shedding mediated by metalloproteinases [shed RAGE (sRAGE)]. Therefore we analyzed whether statins influence the production of soluble RAGE. Lovastatin treatment of either mouse alveol…

medicine.medical_specialtyendocrine system diseasesADAM10Receptor for Advanced Glycation End ProductsBeta-CyclodextrinsQD415-436PharmacologyBiochemistryCell LineRAGE (receptor)MiceEndocrinologyGlycationInternal medicinediabetic complicationsmedicineAnimalsHumansSecretionLovastatincardiovascular diseasesReceptors ImmunologicReceptorResearch ArticlesDose-Response Relationship DrughypercholesterolemiaChemistrybeta-CyclodextrinsHEK 293 cellsTricarboxylic Acidsnutritional and metabolic diseasesCell BiologyBridged Bicyclo Compounds HeterocyclicADAM 10CholesterolFarnesyl-Diphosphate FarnesyltransferaseEndocrinologySolubilitycardiovascular systemLovastatinHydroxymethylglutaryl-CoA Reductase Inhibitorsatherosclerosishuman activitiesmedicine.drugJournal of Lipid Research
researchProduct

Insulin resistance and polycystic ovary syndrome.

2008

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in humans, affecting approximately 7-8% of women of reproductive age. Despite the criteria adopted, PCOS is considered to be a predominantly hyperandrogenetic syndrome and the evaluation of metabolic parameters and insulin sensitivity is not mandatory. Most women with PCOS also exhibit features of the metabolic syndrome, including insulin resistance, obesity and dyslipidaemia. While the association with type 2 diabetes is well established, whether the incidence of cardiovascular disease is increased in women with PCOS remains unclear. Acknowledging the strong impact of insulin-resistance in the genesis of PCOS co…

medicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Type 2 diabetesDiseaseEnvironmentBioinformaticsSettore MED/13 - EndocrinologiaInsulin resistanceRisk FactorsDiabetes mellitusInternal medicinemedicineHumansHypoglycemic AgentsGenetic Predisposition to DiseaseNutrition and Dieteticsbusiness.industryIncidenceHyperandrogenismnutritional and metabolic diseasesmedicine.diseasePolycystic ovaryObesityfemale genital diseases and pregnancy complicationsEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesFemaleInsulin resistance pcosMetabolic syndromeInsulin ResistanceCardiology and Cardiovascular MedicinebusinessPolycystic Ovary SyndromeNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct